CHICAGO, April 25, 2023 /PRNewswire/ -- Convergent Genomics announced UroAmp, the company's genomic urine test that uses next-generation DNA sequencing and machine learning to detect and monitor for bladder cancer, will be the subject of two new studies being...

read more